Long-term Open-Label Safety Study to Evaluate EN3409
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the long-terms study is to evaluate the safety, tolerability, and analgesic
efficacy of EN3409 in subjects with moderate to severe chronic pain requiring continuous
around-the-clock opioid analgesia for an extended period of time.
Phase:
Phase 3
Details
Lead Sponsor:
BioDelivery Sciences International Endo Pharmaceuticals